A newly created tumor-specific fluorescent molecule combined with an imaging system guided surgeons to removing additional tumors not palpable or visible without fluorescence in patients with ovarian cancer.
A new surgical tool that uses light to ensure surgeons removed all of a cancerous tumor was found to correlate well with traditional pathologists' diagnoses, according to a clinical study showing that the tool could soon enable reliable, real-time surgical guidance.
New molecular tools are emerging to identify lung adenocarcinomas during pulmonary resection. The results of a proof-of-concept study suggest that fluorescent imaging of lung cancer during surgery using targeted molecular agents may soon be a reality.
Researchers have successfully tested a new tool that will help surgeons better distinguish cancerous breast tissue from normal tissue, which should lower the mount of repeat procedures needed.
A new study sheds new light on the risks associated with the growing popularity of endoscopic resection in the treatment of localized, early-stage esophageal cancer.
Despite an overall improved mortality seen during the past 10 years, advancing age is associated with higher morbidity and mortality in colorectal cancer resection.
Laparoscopic procedure linked with lower risk of discharge to a nursing facility when compared with open surgery.
Carbon ion radiotherapy (CIRT) appears to be safe and effective for the treatment of persons with unresectable spinal sarcoma, researchers have affirmed.
A specific pattern found in the tumor pathology of some patients with lung cancer is a strong predictor of recurrence, according to a new study.
FOLFIRINOX chemotherapy plus chemoradiation helped make resection possible in locally advanced pancreatic cancer.
Combining cetuximab (Erbitux) with standard therapy improved the resectability of previously inoperable liver metastases of colorectal cancer.
A new type of retinoblastoma, which is a rapidly developing eye cancer that affects very young babies, has been discovered. This finding can immediately change clinical practice and optimize care for these children.
Fluorescence form 5-aminolevulinic acid (5-ALA) has been used to guide resection of recurrent GBM. Before surgery, the patient ingests 5-ALA, then the tumor cells fluoresce intraoperatively in response to certain wavelengths of light.
EGFR mutation is not a prognostic factor in non-small cell lung cancer, but EGFR tyrosine kinase inhibitors may prolong survival after recurrence.
In early non-small cell lung cancer, overall survival was better after surgery than after radiation, but cancer-specific survival was similar.
A new technique has been developed that allows surgeons, during surgery, to identify which lymph nodes are cancerous so that healthy tissue can be saved.
A surgical technique known as intracorporeal cooling and extraction (ICE) may reduce the need for conventional open surgery in kidney cancer.
Chemotherapy after surgery led to higher rates of disease-free and overall survival for women with isolated local or regional recurrence of breast cancer.
Persons with metastatic colorectal cancer or gastrointestinal stromal tumors may garner some survival benefit from regorafenib after standard treatments have failed.
New studies reveal important advances in cancer care quality measurement, physician adherence to quality standards, and end-of-life care, while highlighting the overuse of contralateral prophylactic mastectomy.
Persons with glioblastoma who undergo repeated resections can have improved survival, indicate the findings of a recent study.
A facility favoring early surgical resection of low-grade glioma had better overall survival rates than did a facility favoring watchful waiting.
The risk of uterine cancer recurrence may be increased by waiting too long after a hysterectomy to begin radiation therapy. For patients with uterine cancer who are not receiving chemotherapy, tumors were found to be more likely to return if radiation therapy was delayed 9 weeks or longer following surgery.
Laparoendoscopic single-site surgery (LESS) for removal of a cancerous kidney led to a less painful recovery than did traditional multiport laparoscopy.
Robotic-assisted operations and minimally invasive surgical procedures may extend survival and improve recovery in these patients compared with conventional open operations, according to recent studies presented at the 2012 Annual Clinical Congress of the American College of Surgeons.
Women with chronic preoperative pain were up to three times more likely to report moderate to severe pain on movement after breast cancer surgery.
Persons with more than one glioblastoma tumor upon diagnosis experience significantly worse survival than do patients with a solitary lesion.
Knowing how much time people with pancreatic cancer spend in the hospital or in medical care can help clinicians make treatment recommendations.
Oncologists at M.D. Anderson Cancer Center found the key to screening for pancreatic cancer lies in the interpretation of preoperative CT scans.
A new molecular test is more accurate at predicting high risk for death after surgical resection of early-stage nonsquamous NSCLC.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|